BeyondSpring Inc. (BYSI)
NASDAQ: BYSI · IEX Real-Time Price · USD
2.360
-0.050 (-2.07%)
At close: Jul 2, 2024, 4:00 PM
2.350
-0.010 (-0.42%)
After-hours: Jul 2, 2024, 5:58 PM EDT
BeyondSpring Market Cap
BeyondSpring has a market cap or net worth of $95.11 million as of July 2, 2024. Its market cap has increased by 101.50% in one year.
Market Cap
95.11M
Enterprise Value
81.16M
1-Year Change
101.50%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since March 9, 2017, BeyondSpring's market cap has decreased from $362.10M to $95.11M, a decrease of -73.73%. That is a compound annual growth rate of -16.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 96.40M | 174.64% |
| Dec 29, 2023 | 35.10M | -52.05% |
| Dec 30, 2022 | 73.20M | -58.71% |
| Dec 31, 2021 | 177.30M | -52.38% |
| Dec 31, 2020 | 372.30M | -7.48% |
| Dec 31, 2019 | 402.40M | -4.76% |
| Dec 31, 2018 | 422.50M | -32.59% |
| Dec 29, 2017 | 626.80M | 73.10% |
| Mar 9, 2017 | 362.10M | - |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Karyopharm Therapeutics | 101.62M |
| Immunic | 100.89M |
| Sagimet Biosciences | 100.85M |
| InflaRx | 100.69M |
| RAPT Therapeutics | 100.52M |
| Armata Pharmaceuticals | 99.43M |
| X4 Pharmaceuticals | 98.98M |
| Citius Pharmaceuticals | 98.16M |